Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Shares Down 2.9% – Should You Sell?

Shares of Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) dropped 2.9% during mid-day trading on Tuesday . The company traded as low as $4.4750 and last traded at $4.66. Approximately 374,411 shares were traded during trading, an increase of 82% from the average daily volume of 205,918 shares. The stock had previously closed at $4.80.

Health Sciences Acquisitions Co. 2 Stock Down 2.9%

The business has a fifty day moving average of $4.44 and a two-hundred day moving average of $3.46.

Health Sciences Acquisitions Co. 2 Company Profile

Health Sciences Acquisitions Co 2 is a Delaware‐incorporated special purpose acquisition company (SPAC) established to pursue a business combination with a company in the health sciences sector. Listed on the Nasdaq under the ticker HSAQ, the firm completed an initial public offering in early 2021, raising capital through the sale of units comprised of common stock and warrants.

As a blank‐check vehicle, Health Sciences Acquisitions Co 2 does not engage in commercial operations; rather, it focuses exclusively on identifying and combining with a private company operating in biotechnology, pharmaceuticals, medical devices or related life sciences fields.